For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Praecis Pharmaceuticals, Inc.

USPTO Granted Patents = 43

% Expired Patents = 46.5

EPO Patents = 2

Forward Citations = 964

Loading Chart...

Loading Chart...

59 inventors (with patents filed for the assignee):

Malcolm L Gefter (24 out of 39 patents)

Marc B Garnick (15 out of 21 patents)

Mark A Findeis (14 out of 17 patents)

4. Gary Fred Musso (13 out of 24 patents)

5. Christopher C Arico-Muendel (12 out of 16 patents)

6. Ethan R Signer (12 out of 12 patents)

7. Christopher Self (11 out of 23 patents)

8. Gary Olson (10 out of 31 patents)

9. James Wakefield (10 out of 10 patents)

10. Christopher J Molineaux (10 out of 11 patents)

11. Jens Birktoft (9 out of 9 patents)

12. Lily Lee (9 out of 12 patents)

13. Charles Michael Cook (9 out of 14 patents)

14. Kathryn Phillips (8 out of 12 patents)

15. Barry A Morgan (8 out of 35 patents)

Core Competencies:

Encoded Libraries

Amyloid Aggregation

Sphingosine-1-Phosphate

Melanoma Treatments

Angiogenesis Modulation

Sustained Drug Delivery

LHRH Antagonists

Peptide Compounds

FGF Receptor Activity

Pharmaceutical Compositions

Cancer Therapies

Hormone-Dependent Conditions

43 patents: Sort by Forward Citations

1. 7972992 - Methods for synthesis of encoded libraries (2011-07-05),

2. 7935658 - Methods for synthesis of encoded libraries (2011-05-03),

3. 7803774 - Modulators of β-amyloid peptide aggregation (2010-09-28),

4. 7759370 - Sphingosine-1-phosphate (SIP) receptor agonists (2010-07-20),

5. 7658917 - Modulators of amyloid aggregation (2010-02-09),

6. 7405194 - Therapeutic agents and methods of use thereof for the treatment of melanoma (2008-07-29),

7. 7348307 - Methionine aminopeptidase-2 inhibitors and methods of use thereof (2008-03-25),

8. 7268117 - Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis (2007-09-11),

9. 7268111 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2007-09-11),

10. 7241812 - Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity (2007-07-10),

11. 7175828 - Modulators of β-amyloid peptide aggregation comprising D-amino acids (2007-02-13),

12. 7157420 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2007-01-02),

13. 7109171 - Methods for treating FSH related conditions with GnRH antagonists (2006-09-19),

14. 7105482 - Methionine aminopeptidase-2 inhibitors and methods of use thereof (2006-09-12),

15. 7084108 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2006-08-01),

Company Overview

Praecis Pharmaceuticals, Inc. is a biotechnology company based in Waltham, MA, specializing in the development of innovative therapies targeting complex diseases. The company focuses on advanced technologies such as encoded libraries and sphingosine-1-phosphate receptor agonists to address conditions like melanoma and endometriosis. Praecis is also engaged in research related to angiogenesis modulation and sustained drug delivery, aiming to enhance treatment efficacy and patient outcomes in various therapeutic areas.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

43 Patents

#36 in Waltham, MA

#467 in Massachusetts

#8,099 in US

#16,040 in the World

Waltham, MA, United States of America

Praecis Pharmaceuticals, Inc.

Forward Citations = 964

59 inventors:

Malcolm L Gefter (24 out of 39 patents)

Marc B Garnick (15 out of 21 patents)

Mark A Findeis (14 out of 17 patents)

4. Gary Fred Musso (13 out of 24 patents)

5. Christopher C Arico-Muendel (12 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Praecis Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/praecis-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…